These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16507272)

  • 1. Late effects of treatment for Hodgkin lymphoma.
    Friedman DL; Constine LS
    J Natl Compr Canc Netw; 2006 Mar; 4(3):249-57. PubMed ID: 16507272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late effects of therapy for Hodgkin's lymphoma.
    Adams MJ; Constine LS; Lipshultz SE
    Curr Hematol Malig Rep; 2007 Jul; 2(3):143-50. PubMed ID: 20425363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the risk of therapy-associated complications in survivors of Hodgkin lymphoma.
    Travis LB
    Hematology Am Soc Hematol Educ Program; 2007; ():192-6. PubMed ID: 18024629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term complications in Hodgkin's lymphoma survivors.
    Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
    Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA).
    Krul IM; Opstal-van Winden AWJ; Zijlstra JM; Appelman Y; Schagen SB; Meijboom LJ; Serné E; Lambalk CB; Lips P; van Dulmen-den Broeder E; Hauptmann M; Daniëls LA; Aleman BMP; van Leeuwen FE
    BMJ Open; 2018 Sep; 8(9):e018120. PubMed ID: 30206072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 10. Late effects of treatment for germ cell tumors during childhood and adolescence.
    Hale GA; Marina NM; Jones-Wallace D; Greenwald CA; Jenkins JJ; Rao BN; Luo X; Hudson MM
    J Pediatr Hematol Oncol; 1999; 21(2):115-22. PubMed ID: 10206457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late effects in survivors of bone tumors.
    Mosher RB; McCarthy BJ
    J Pediatr Oncol Nurs; 1998 Apr; 15(2):72-84; quiz 85-9. PubMed ID: 9597816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
    Leahy Y
    Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-art issues in Hodgkin's lymphoma survivorship.
    Baxi SS; Matasar MJ
    Curr Oncol Rep; 2010 Nov; 12(6):366-73. PubMed ID: 20734173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
    Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
    Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The late effects of childhood cancer therapy.
    Dickerman JD
    Pediatrics; 2007 Mar; 119(3):554-68. PubMed ID: 17332209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
    Matasar MJ; Ford JS; Riedel ER; Salz T; Oeffinger KC; Straus DJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25717170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.